Riskpilot← Back to searchSign inGet full accessMedicarol AB
ABActiveOrg 5591356554Lindöhällsvägen 58General medical practice activities · NACE 8621Est. 20170 employees
Revenue 2025
SEK 0
EBITDA margin
—
+10% vs 2024
Equity ratio
58.2%
Financial strength
Net profit 2025
SEK 69K
-83% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -26K | +10% |
| Net profit | SEK 69K | -83% |
| Total assets | SEK 292K | -63% |
| Equity | SEK 170K | -76% |
| Employees | 0 | — |
Legal name
Medicarol AB
Org number
5591356554
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
28 november 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Medicinsk verksamhet. Förvaltning av tillgångar.
Address
Lindöhällsvägen 58
Email
carin.tjellstrom@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 1 250 | 820 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | 1 235 | 791 | −34 | −33 | −21 | −29 | −26 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 235 | 791 | −34 | −33 | −21 | −29 | −26 |
| Net financials | — | — | 7 | −116 | 80 | 32 | 125 |
| Profit before tax | 935 | 593 | −41 | −92 | 60 | 502 | 99 |
| Tax | −206 | −127 | −0 | −0 | −2 | −105 | −30 |
| Net profit | 729 | 466 | −41 | −92 | 58 | 397 | 69 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 1 295 | 1 671 | 1 037 | 940 | 973 | 792 | 292 |
| Equity | 779 | 905 | 529 | 247 | 305 | 701 | 170 |
| Long-term debt | 0 | 0 | 0 | 185 | 160 | 0 | 0 |
| Short-term debt | 216 | 267 | 10 | 10 | 10 | 91 | 122 |
| Total debt | 216 | 267 | 10 | 195 | 170 | 91 | 122 |
EBITDA margin
-2600000.0%
This company
15.8%
Market median
-16455796% vs market
20192025
Equity ratio
58.2%
This company
38.2%
Market median
+52% vs market
20192025
Return on equity
40.6%
This company
18.4%
Market median
+121% vs market
20192025
Net profit margin
6900000.0%
This company
8.1%
Market median
+85185085% vs market
20192025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192025
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20192025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2017-11-01 – 2019-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 | — | — |
BU | Audit | 2025 | — | — |
IC Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medicarol AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Arthur Einar Tjellström | Deputy Chief Executive Officer | 0 companies |
| Bertil Ulf Moritz Raue | Audit | 0 companies |
| Inger Carin E Rolander Tjellström | Chief Executive Officer | 0 companies |